Revised guideline aims to strengthen global approach to development of new antibacterial medicines

January 14, 2019 – EMA has published a revision of its guideline on the evaluation of human medicines indicated for the treatment of bacterial infections for a six-month public consultation. Stakeholders can send their comments by 31 July 2019 to idwpecretariat@ema.europa.eu using the template provided. EMA plays an important role in the fight against antimicrobial resistance by supporting the development of new medicines and treatment approaches … (leggi tutto)